...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Question for the board!
1
Jan 22, 2019 11:11AM

I can't remember when I heard it but it seems to me that DM once said that a listing would probably come when there is an event substantial enough to drive the new listing. I might be remembering wrong but it seems as though he said that once. There are also costs to being listed that they are saving for now. 

3
Jan 22, 2019 12:30PM
2
Jan 22, 2019 12:46PM
5
Jan 22, 2019 01:39PM
4
Jan 22, 2019 01:40PM
3
Jan 22, 2019 02:24PM
6
Jan 22, 2019 04:23PM
5
Jan 22, 2019 04:53PM
3
Jan 22, 2019 05:56PM
Share
New Message
Please login to post a reply